Log inSign up
QIAGEN
4,687 posts
Image
user avatar
QIAGEN
@QIAGEN
#QIAGEN is a leading provider of molecular Sample to Insight solutions. Impressum: qiagen.com/de/trademarks-…
Hilden, Germany
qiagen.com
Joined May 2009
770
Following
16K
Followers
  • Pinned
    user avatar
    QIAGEN
    @QIAGEN
    Jun 16
    The shift from qPCR to digital PCR is accelerating, and gene expression is where it gets really interesting. Learn more 👉 tinyurl.com/mrpunddu #QGEN #QIA
    Image
    117
  • user avatar
    QIAGEN
    @QIAGEN
    Jun 9, 2017
    Check out the great time we had at #ASCO17 in Chicago and enjoy the flashback! x.com/i/moments/8724…
  • user avatar
    QIAGEN
    @QIAGEN
    Feb 28, 2019
    Did you know that there are 7,000 rare diseases? #RareDiseaseDay #ShowYourRare Find out more: bit.ly/2tJ76hA
    Image
  • user avatar
    QIAGEN
    @QIAGEN
    Mar 17, 2020
    We are dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus #COVID19
    Image
    Dramatically ramping up global production capacity
    From qiagen.com
  • user avatar
    QIAGEN
    @QIAGEN
    Oct 12, 2019
    “Nothing else matches the consistency, quality and concentration of RNA that I get from these kits.” – Asha Palat, department of biology and biochemistry at the University of Houston
    Image
    QIAseq FastSelect: Attacking cancer from all angles
    From qiagen.com
  • user avatar
    QIAGEN
    @QIAGEN
    Feb 28, 2018
    Did you know that 1 out of 20 people have a rare disease? #RareDiseaseDay #ShowYourRare #MyRare
    Image
  • user avatar
    QIAGEN
    @QIAGEN
    Jan 15, 2020
    The World Health Organization estimates that a startling one in four people worldwide is infected with tuberculosis. Learn how the Omani government is pioneering #TB Management. #EndTB #StopTB
    Image
    00:00
    Testing millions to stop tuberculosis migration
    From qiagen.com
  • user avatar
    QIAGEN
    @QIAGEN
    Jan 22, 2020
    “Treating latent TB means fewer drugs, fewer side effects, and shorter times for therapy.” - Dr. Eskild Petersen, Ministry of Health, Oman | Learn how ⬇️
    Image
    Testing millions to stop tuberculosis migration
    From qiagen.com
  • user avatar
    QIAGEN
    @QIAGEN
    Feb 12, 2017
    Nasim fled the war in Syria and works now at our molecular diagnostic products department. Find out more: fal.cn/Qg4M
    Image
  • user avatar
    QIAGEN
    @QIAGEN
    Mar 3, 2020
    “This strategic step with Thermo Fisher will enable us to enter a promising new era and will give our employees the opportunity to have an even greater impact." - Thierry Bernard, interim CEO of QIAGEN N.V. and SVP, head of the molecular diagnostics business area
    Image
    Thermo Fisher Scientific to Acquire QIAGEN N.V.
    From qiagen.com
  • user avatar
    QIAGEN
    @QIAGEN
    Nov 15, 2019
    A pioneer in the field of immunotherapy discovers and manipulates specific immune cells to defend against cancer using QIAGEN’s next-generation sequencing technologies:
    Image
    The immune system as medicine
    From qiagen.com
  • user avatar
    QIAGEN
    @QIAGEN
    Nov 15, 2019
    “My research targets ways to monitor the immune responses of cancer patients treated with anti PD-1 antibodies, as well as the best selection of T-cells for adoptive cell transfer.” - Nathalie Labarrière, French Institute of Health and Medical Research, University of Nantes.
    Image
    The immune system as medicine
    From qiagen.com
  • user avatar
    QIAGEN
    @QIAGEN
    Feb 9, 2017
    We support the integration of #refugees into the local labor market. Meet our interns Nasim, Mhamud and Fadi vimeo.com/202928404
  • user avatar
    QIAGEN
    @QIAGEN
    Apr 7, 2017
    ⚡️ Happy to share our favorite moments from #AMPGlobal2017! Browse through our updatesd from the event: x.com/i/moments/8499…

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement